Dr. Balmaceda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12801 East 17th Avenue 8122
Aurora, CO 80045Phone+1 913-588-3974Fax+1 913-588-0593
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2022 - 2025
- University of Kansas School of MedicineResidency, Internal Medicine, 2019 - 2022
- University of Kansas School of MedicineClass of 2019, KUMC Research Institute GI Cancer Research Award
- University of KansasBS, Biochemistry, Heidi Everley Research Award, 2011 - 2015
Certifications & Licensure
- KS State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.Aleksander Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley
Annals of Hematology. 2024-08-01 - State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care.Nicole Baranda Balmaceda, Angelica Petrillo, Mridula Krishnan, Joseph J Zhao, Sunnie Kim
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01 - Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions.Nicole Baranda Balmaceda, Sunnie S Kim
Journal of Gastrointestinal Cancer. 2024-03-01
Journal Articles
- State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision CareNicole Balmaceda, American Society of Clinical Oncology Educational Book, 5/21/2024
- Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort studyNagaraj G, Vinayak S, Khaki AR, Sun T, Kuderer NM, Aboulafia DM, Acoba JD, Awosika J, Bakouny Z, Balmaceda NB, Bao T, Bashir B, Berg S, Bilen MA, Bindal P, Blau S, Bod..., eLife, 10/17/2023
- Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19Ziad Bakouny, MD; Chris Labaki, MD; Punita Grover, MD; et al, JAMA Oncology, 11/3/2022
- Join now to see all
Abstracts/Posters
- Effect of durable hematocrit control and minimal thrombotic risk in real-world polycythemia vera patients treated with ruxolitinib.Aleksander Lech Chojecki, Danielle Boselli, Allison Dortilus, Issam Hamadeh, Stephanie Begley, Tommy Chen, Rupali Bose, Nikolai Alexandrovich Podoltsev, Amer Methqal Z..., Journal of Clinical Oncology , 2023 ASCO, 6/1/2023
Professional Memberships
- American Association for Cancer ResearchMember
- American College of PhysiciansACP Council Student Representative
- American Medical AssociationMember
- American Society of Clinical OncologyMember
- European Society of Medical OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: